News
This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback